NCT03164265View on ClinicalTrials.gov

DCreg in Living Donor Liver Transplantation

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 30, 2017

Primary Completion Date

July 15, 2024

Study Completion Date

July 15, 2024

Conditions
Living Donor Liver Transplantation
Interventions
BIOLOGICAL

Regulatory Donor-Derived Dendritic Cell infusion

Regulatory dendritic cells that were prepared from a donor leukapheresis will be infused into liver transplant recipients 7 days prior to surgery

Trial Locations (1)

15261

UPMC, Pittsburgh

All Listed Sponsors
collaborator

University of Pittsburgh

OTHER

lead

Angus W. Thomson PhD DSc

OTHER

NCT03164265 - DCreg in Living Donor Liver Transplantation | Biotech Hunter | Biotech Hunter